Petros Pharmaceuticals, Inc. (PTPI) SEC Filings & Financial Intelligence
Petros Pharmaceuticals, Inc. (PTPI) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PTPI
CIK: 1815903
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
HTL International, LLC
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerRobert Armstrong
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-30 | 2026-09-30 | FORM 8-K | 0001104659-26-112399 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001104659-26-095979 | View SEC Doc Filr Page |
| 3 | 2026-06-25 | 2026-06-18 | OWNERSHIP DOCUMENT | 0001104659-26-077822 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | FORM 8-K | 0001104659-26-075849 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-05 | OWNERSHIP DOCUMENT | 0001104659-26-071436 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-05 | OWNERSHIP DOCUMENT | 0001104659-26-071048 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-05 | OWNERSHIP DOCUMENT | 0001104659-26-071039 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-05 | OWNERSHIP DOCUMENT | 0001104659-26-071038 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-05 | FORM 8-K | 0001104659-26-071027 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001104659-26-060359 | View SEC Doc Filr Page |
| 10-K | 2026-04-15 | 2025-12-31 | 10-K | 0001104659-26-043822 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NT 10-K | 0001104659-26-037800 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0000930413-26-000426 | View SEC Doc Filr Page |
| 4 | 2026-01-06 | 2026-01-02 | OWNERSHIP DOCUMENT | 0001104659-26-001417 | View SEC Doc Filr Page |
| 4 | 2026-01-02 | 2026-01-02 | OWNERSHIP DOCUMENT | 0001104659-26-000238 | View SEC Doc Filr Page |
| 8-K | 2026-01-02 | 2026-01-01 | FORM 8-K | 0001104659-26-000236 | View SEC Doc Filr Page |
| 4 | 2026-01-02 | 2026-01-02 | OWNERSHIP DOCUMENT | 0001104659-26-000237 | View SEC Doc Filr Page |
| 4 | 2026-01-02 | 2026-01-02 | OWNERSHIP DOCUMENT | 0001104659-26-000233 | View SEC Doc Filr Page |
| 25-NSE | 2025-11-20 | — | 25-NSE Filing | 0001354457-25-001163 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001104659-25-111338 | View SEC Doc Filr Page |
| 8-K | 2025-11-07 | 2025-11-03 | FORM 8-K | 0001104659-25-108552 | View SEC Doc Filr Page |
| 8-K | 2025-09-05 | 2025-08-29 | FORM 8-K | 0001104659-25-087887 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-08-15 | — | SCHEDULE 13G/A Filing | 0000930413-25-002483 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0001410578-25-001811 | View SEC Doc Filr Page |
| 8-K | 2025-06-20 | 2025-06-16 | FORM 8-K | 0001104659-25-061230 | View SEC Doc Filr Page |